175 related articles for article (PubMed ID: 38151625)
1. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe.
Tamayo NA; Bourbeau MP; Allen JR; Ashton KS; Chen JJ; Kaller MR; Nguyen TT; Nishimura N; Pettus LH; Walton M; Belmontes B; Moriguchi J; Chen K; McCarter JD; Hanestad K; Chung G; Ninniri MSS; Sun J; Poppe L; Spahr C; Hui J; Jia L; Wu T; Dahal UP; Edson KZ; Payton M
J Med Chem; 2022 Mar; 65(6):4972-4990. PubMed ID: 35286090
[TBL] [Abstract][Full Text] [Related]
3. Chromosomally unstable tumor cells specifically require KIF18A for proliferation.
Marquis C; Fonseca CL; Queen KA; Wood L; Vandal SE; Malaby HLH; Clayton JE; Stumpff J
Nat Commun; 2021 Feb; 12(1):1213. PubMed ID: 33619254
[TBL] [Abstract][Full Text] [Related]
4. Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells.
Schutt KL; Queen KA; Fisher K; Budington O; Mao W; Liu W; Gu X; Xiao Y; Aswad F; Joseph J; Stumpff J
Front Mol Biosci; 2024; 11():1328077. PubMed ID: 38410188
[No Abstract] [Full Text] [Related]
5. Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells.
Schutt K; Queen KA; Fisher K; Budington O; Mao W; Liu W; Xiao Y; Aswad F; Joseph J; Stumpff J
bioRxiv; 2023 Oct; ():. PubMed ID: 37905069
[TBL] [Abstract][Full Text] [Related]
6. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition.
Cohen-Sharir Y; McFarland JM; Abdusamad M; Marquis C; Bernhard SV; Kazachkova M; Tang H; Ippolito MR; Laue K; Zerbib J; Malaby HLH; Jones A; Stautmeister LM; Bockaj I; Wardenaar R; Lyons N; Nagaraja A; Bass AJ; Spierings DCJ; Foijer F; Beroukhim R; Santaguida S; Golub TR; Stumpff J; Storchová Z; Ben-David U
Nature; 2021 Feb; 590(7846):486-491. PubMed ID: 33505028
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells.
Quinton RJ; DiDomizio A; Vittoria MA; Kotýnková K; Ticas CJ; Patel S; Koga Y; Vakhshoorzadeh J; Hermance N; Kuroda TS; Parulekar N; Taylor AM; Manning AL; Campbell JD; Ganem NJ
Nature; 2021 Feb; 590(7846):492-497. PubMed ID: 33505027
[TBL] [Abstract][Full Text] [Related]
8. Weakened APC/C activity at mitotic exit drives cancer vulnerability to KIF18A inhibition.
Gliech CR; Yeow ZY; Tapias-Gomez D; Yang Y; Huang Z; Tijhuis AE; Spierings DC; Foijer F; Chung G; Tamayo N; Bahrami-Nejad Z; Collins P; Nguyen TT; Plata Stapper A; Hughes PE; Payton M; Holland AJ
EMBO J; 2024 Mar; 43(5):666-694. PubMed ID: 38279026
[TBL] [Abstract][Full Text] [Related]
9. Loss of Kif18A Results in Spindle Assembly Checkpoint Activation at Microtubule-Attached Kinetochores.
Janssen LME; Averink TV; Blomen VA; Brummelkamp TR; Medema RH; Raaijmakers JA
Curr Biol; 2018 Sep; 28(17):2685-2696.e4. PubMed ID: 30122526
[TBL] [Abstract][Full Text] [Related]
10. Kif18A is involved in human breast carcinogenesis.
Zhang C; Zhu C; Chen H; Li L; Guo L; Jiang W; Lu SH
Carcinogenesis; 2010 Sep; 31(9):1676-84. PubMed ID: 20595236
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of optimized inhibitors of the mitotic kinesin Kif18A.
Braun J; Möckel MM; Strittmatter T; Marx A; Groth U; Mayer TU
ACS Chem Biol; 2015 Feb; 10(2):554-60. PubMed ID: 25402598
[TBL] [Abstract][Full Text] [Related]
12. Kif18a is specifically required for mitotic progression during germ line development.
Czechanski A; Kim H; Byers C; Greenstein I; Stumpff J; Reinholdt LG
Dev Biol; 2015 Jun; 402(2):253-262. PubMed ID: 25824710
[TBL] [Abstract][Full Text] [Related]
13. Germinal Cell Aplasia in Kif18a Mutant Male Mice Due to Impaired Chromosome Congression and Dysregulated BubR1 and CENP-E.
Liu XS; Zhao XD; Wang X; Yao YX; Zhang LL; Shu RZ; Ren WH; Huang Y; Huang L; Gu MM; Kuang Y; Wang L; Lu SY; Chi J; Fen JS; Wang YF; Fei J; Dai W; Wang ZG
Genes Cancer; 2010 Jan; 1(1):26-39. PubMed ID: 20981276
[TBL] [Abstract][Full Text] [Related]
14. Defects in chromosome congression and mitotic progression in KIF18A-deficient cells are partly mediated through impaired functions of CENP-E.
Huang Y; Yao Y; Xu HZ; Wang ZG; Lu L; Dai W
Cell Cycle; 2009 Aug; 8(16):2643-9. PubMed ID: 19625775
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of the KIF18A motor protein in cancers with chromosomal instability.
Nat Cancer; 2024 Jan; 5(1):10-11. PubMed ID: 38267629
[No Abstract] [Full Text] [Related]
16. Kinesin-binding protein ensures accurate chromosome segregation by buffering KIF18A and KIF15.
Malaby HLH; Dumas ME; Ohi R; Stumpff J
J Cell Biol; 2019 Apr; 218(4):1218-1234. PubMed ID: 30709852
[TBL] [Abstract][Full Text] [Related]
17. Kinesin KIF18A is a novel PUM-regulated target promoting mitotic progression and survival of a human male germ cell line.
Smialek MJ; Kuczynska B; Ilaslan E; Janecki DM; Sajek MP; Kusz-Zamelczyk K; Jaruzelska J
J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32094263
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C β inhibition by enzastaurin leads to mitotic missegregation and preferential cytotoxicity toward colorectal cancer cells with chromosomal instability (CIN).
Ouaret D; Larsen AK
Cell Cycle; 2014; 13(17):2697-706. PubMed ID: 25486357
[TBL] [Abstract][Full Text] [Related]
19. Sumoylation of Kif18A plays a role in regulating mitotic progression.
Yang F; Chen Y; Dai W
BMC Cancer; 2015 Mar; 15():197. PubMed ID: 25884224
[TBL] [Abstract][Full Text] [Related]
20. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
